Cardioloxía
Servizo
Fernando
Rivero Crespo
Publicacións nas que colabora con Fernando Rivero Crespo (16)
2024
-
A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study
JACC: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 756-767
2023
-
Changes in the Treatment Strategy Following Intracoronary Pressure Wire in a Contemporaneous Real-Life Cohort of Patients With Intermediate Coronary Stenosis. Results From a Nationwide Registry
Cardiovascular Revascularization Medicine, Vol. 51, pp. 55-64
-
Safety and feasibility of transradial access for percutaneous coronary intervention in chronic total occlusions
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 253-260
2022
-
Clinical implications of arterial hypertension in patients with spontaneous coronary artery dissection
Coronary artery disease, Vol. 33, Núm. 2, pp. 75-80
-
Plaque modification in calcified chronic total occlusions: the PLACCTON study
Revista Espanola de Cardiologia, Vol. 75, Núm. 3, pp. 213-222
-
Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study)
American Journal of Cardiology, Vol. 162, pp. 31-40
2021
-
Impact of morbid obesity and obesity phenotype on outcomes after transcatheter aortic valve replacement
Journal of the American Heart Association, Vol. 10, Núm. 12
-
Spontaneous coronary artery dissection in Spain: clinical and angiographic characteristics, management, and in-hospital events
Revista Espanola de Cardiologia, Vol. 74, Núm. 1, pp. 15-23
2020
-
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with st-segment elevation myocardial infarction: Vascular healing outcomes from the magstemi trial
EuroIntervention, Vol. 16, Núm. 11, pp. E913-E921
-
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience
Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
2016
-
Comparison of the Efficacy of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients with In-Stent Restenosis (from the RIBS IV and v Randomized Clinical Trials)
American Journal of Cardiology, Vol. 117, Núm. 4, pp. 546-554
2015
-
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial
Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33
-
Erratum: A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: The RIBS IV randomized clinical trial (Journal of the American College of Cardiology (2015) 66 (23-33))
Journal of the American College of Cardiology
2013
-
Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry)
American Journal of Cardiology, Vol. 111, Núm. 5, pp. 676-683
2010
-
Thrombosis of second-generation drug-eluting stents in real practice: Results from the multicenter Spanish registry ESTROFA-2 (estudio espaol sobre trombosis de stents farmacoactivos de segunda generacion-2)
JACC: Cardiovascular Interventions, Vol. 3, Núm. 9, pp. 911-919